Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
342 hedge funds and large institutions have $9B invested in Syneos Health, Inc. Class A Common Stock in 2021 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 171 increasing their positions, 66 reducing their positions, and 36 closing their positions.
159% more repeat investments, than reductions
Existing positions increased: 171 | Existing positions reduced: 66
72% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 36
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
48% more call options, than puts
Call options by funds: $7.96M | Put options by funds: $5.37M
13% more capital invested
Capital invested by funds: $7.96B → $9B (+$1.05B)
7% more funds holding
Funds holding: 319 → 342 (+23)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$235M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$158M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$152M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$100M |
| 5 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
+$79.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Advent International
Boston,
Massachusetts
|
-$817M |
| 2 |
THLTP
Thomas H. Lee (THL) Partners
Boston,
Massachusetts
|
-$691M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$50.4M |
| 4 |
Goldman Sachs
New York
|
-$35M |
| 5 |
Bank of New York Mellon
New York
|
-$27.2M |
SYNH Hedge Fund Activity: Q2 2021 in Review
342 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q2 2021, worth a combined $9B — up 13% from $7.96B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new SYNH positions and 36 closed out — a net gain of 26 holders — while 171 added to existing stakes and 66 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $235M. The largest seller was Advent International, exiting entirely with an estimated $817M sold.
- 342 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q2 2021, up from 319 in Q1 2021.
- Funds reported $9B of Syneos Health, Inc. Class A Common Stock stock for Q2 2021, up 13% quarter-over-quarter.
- 62 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q2 2021 and 36 closed out, a net change of +26 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q2 2021 was Wellington Management Group, an estimated $235M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q2 2021 was Advent International, an estimated $817M sold.
Based on aggregated 13F filings for Q2 2021.